Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Floseal hemostatic matrix
DRUG
3 trials
Sponsors
University of Alberta
, Chang Gung Memorial Hospital
, BMI Korea
Conditions
Epistaxis
Hip Replacement, Total
Surgical Hemorrhage
Phase 3
A Phase III Study of Hemofence for Hemostasis in Patients With Uncontrolled Exudative Hemorrhage During Spinal Or Orthopedic Surgery
Completed
NCT07824024
BMI Korea
Surgical Hemorrhage
Start: 2020-12-03
End: 2022-04-19
Updated: 2026-09-17
Phase 4
Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty
NCT03623789
Chang Gung Memorial Hospital
Hip Replacement, Total
Start: 2018-08-15
End: 2020-07-31
Target: 90
Updated: 2020-01-18
Unknown Phase
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
Completed
NCT02488135
University of Alberta
Epistaxis
Start: 2015-07-01
End: 2017-03-01
Updated: 2023-01-18
Related Papers
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. Traditional nasal packing: A prospective randomized control trial
Journal of Otolaryngology - Head and Neck Surgery
2018-01-01
23 citations